Stock listing
NASDAQ:MEDP Medpace Holdings, Inc. Stock
Home listing (NASDAQ) of Medpace Holdings, Inc.
Follow Medpace Holdings, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:MEDP
$610.54 USD -36.33 (-5.6%)
Close on Nov 20, 2026
- Day range
- $606.73 – $633.87 USDNov 20, 2026
- Volume
- 236,685 sharesNov 20, 2026
- Market cap
- $17.08B USDAt the close on Nov 20, 2026 · price × 27.97M shares outstanding
- 52-week range
- $373.00 – $693.72 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $162.6M USDMedian day 225,900 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:MEDP · Home | $610.54 USD | -36.33 (-5.6%) | 236,685 | $632.09 | $633.87 | $606.73 | $646.87 | Close on Nov 20, 2026 |
| Frankfurt:01P | €553.20 EUR | -22.80 (-4.0%) | — | €566.40 | €572.20 | €553.20 | €576.00 | Close on Nov 20, 2026 |
| Stuttgart:01P | €562.40 EUR | -21.80 (-3.7%) | 7 | €576.60 | €588.80 | €562.40 | €584.20 | Close on Nov 5, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:MEDP · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $610.54 | -36.33 | -5.6% | $632.09 | $633.87 | $606.73 | 236,685 | |
| $646.87 | -6.22 | -1.0% | $649.79 | $657.23 | $643.69 | 211,741 | |
| $653.09 | +4.89 | +0.8% | $646.19 | $653.70 | $639.21 | 175,847 | |
| $648.20 | -5.74 | -0.9% | $653.94 | $656.56 | $644.30 | 226,126 | |
| $653.94 | -2.90 | -0.4% | $660.25 | $660.25 | $644.77 | 105,447 | |
| $656.84 | -7.93 | -1.2% | $658.00 | $661.02 | $648.35 | 142,179 | |
| $664.77 | +0.23 | 0.0% | $669.57 | $670.45 | $660.72 | 134,530 | |
| $664.54 | -8.39 | -1.2% | $671.92 | $671.92 | $661.41 | 165,201 | |
| $672.93 | +19.82 | +3.0% | $659.94 | $679.18 | $655.31 | 219,153 | |
| $653.11 | +18.13 | +2.9% | $635.01 | $657.77 | $635.00 | 231,621 | |
| $634.98 | -21.79 | -3.3% | $658.65 | $664.57 | $632.11 | 315,837 | |
| $656.77 | -6.72 | -1.0% | $672.72 | $676.68 | $647.89 | 232,642 | |
| $663.49 | +15.35 | +2.4% | $648.80 | $673.25 | $648.26 | 229,519 | |
| $648.14 | -3.87 | -0.6% | $650.33 | $653.67 | $640.00 | 198,552 | |
| $652.01 | -25.55 | -3.8% | $677.85 | $677.85 | $648.11 | 219,433 | |
| $677.56 | -15.12 | -2.2% | $687.83 | $690.00 | $676.32 | 250,314 | |
| $692.68 | +18.89 | +2.8% | $671.56 | $693.72 | $671.56 | 301,484 | |
| $673.79 | -2.98 | -0.4% | $670.67 | $680.38 | $669.76 | 195,595 | |
| $676.77 | +7.575 | +1.1% | $675.00 | $678.23 | $663.61 | 305,671 | |
| $669.20 | +15.24 | +2.3% | $654.98 | $670.18 | $645.93 | 309,400 | |
| $653.96 | -8.52 | -1.3% | $657.11 | $684.52 | $645.30 | 893,800 | |
| $662.48 | +40.05 | +6.4% | $614.98 | $666.65 | $614.98 | 1,025,800 | |
| $622.43 | +2.77 | +0.4% | $626.64 | $637.15 | $613.13 | 403,800 | |
| $619.66 | +1.19 | +0.2% | $619.33 | $625.69 | $616.14 | 247,100 | |
| $618.47 | -10.13 | -1.6% | $630.29 | $632.33 | $610.05 | 325,100 | |
| $628.60 | +11.97 | +1.9% | $622.83 | $635.31 | $617.60 | 391,800 | |
| $616.63 | +6.74 | +1.1% | $605.76 | $630.88 | $605.76 | 311,200 | |
| $609.89 | -10.16 | -1.6% | $620.05 | $620.76 | $609.48 | 155,300 | |
| $620.05 | +8.00 | +1.3% | $612.70 | $623.11 | $608.71 | 176,200 | |
| $612.05 | +9.35 | +1.6% | $602.70 | $620.25 | $602.70 | 159,800 | |
| $602.70 | -1.55 | -0.3% | $602.43 | $604.56 | $590.46 | 223,100 | |
| $604.25 | +1.35 | +0.2% | $600.00 | $615.63 | $596.08 | 207,600 | |
| $602.90 | -17.61 | -2.8% | $624.86 | $642.65 | $601.36 | 219,100 | |
| $620.51 | +21.04 | +3.5% | $601.94 | $623.98 | $601.94 | 341,200 | |
| $599.47 | +1.39 | +0.2% | $593.03 | $609.75 | $587.39 | 303,700 | |
| $598.08 | -26.10 | -4.2% | $627.47 | $628.60 | $597.37 | 233,400 | |
| $624.18 | +2.07 | +0.3% | $622.60 | $628.69 | $614.30 | 306,600 | |
| $622.11 | +6.17 | +1.0% | $612.25 | $622.70 | $610.06 | 250,700 | |
| $615.94 | -2.94 | -0.5% | $616.16 | $621.62 | $608.05 | 238,700 | |
| $618.88 | -1.71 | -0.3% | $620.60 | $620.60 | $608.11 | 229,100 | |
| $620.59 | +3.44 | +0.6% | $612.30 | $626.83 | $610.79 | 308,800 | |
| $617.15 | -13.04 | -2.1% | $630.06 | $637.65 | $614.18 | 275,700 | |
| $630.19 | +5.99 | +1.0% | $624.02 | $632.72 | $619.62 | 303,000 | |
| $624.20 | +11.87 | +1.9% | $614.12 | $627.04 | $613.10 | 188,200 | |
| $612.33 | -2.85 | -0.5% | $615.41 | $619.41 | $608.54 | 522,200 | |
| $615.18 | -1.26 | -0.2% | $620.00 | $622.26 | $608.52 | 225,300 | |
| $616.44 | -4.04 | -0.7% | $616.99 | $625.01 | $612.53 | 208,100 | |
| $620.48 | +25.07 | +4.2% | $594.30 | $623.03 | $594.08 | 303,900 | |
| $595.41 | +7.89 | +1.3% | $595.99 | $600.93 | $589.44 | 201,000 | |
| $587.52 | +4.36 | +0.7% | $584.72 | $595.28 | $584.72 | 159,100 | |
| $583.16 | -3.14 | -0.5% | $582.68 | $587.67 | $577.64 | 195,500 | |
| $586.30 | -4.59 | -0.8% | $590.00 | $590.00 | $577.69 | 206,900 | |
| $590.89 | -0.40 | -0.1% | $590.95 | $596.98 | $587.09 | 185,200 | |
| $591.29 | -2.10 | -0.4% | $585.10 | $596.00 | $585.00 | 146,400 | |
| $593.39 | +0.37 | +0.1% | $594.33 | $599.25 | $586.52 | 143,200 | |
| $593.02 | +9.81 | +1.7% | $583.65 | $593.72 | $581.78 | 204,200 | |
| $583.21 | -10.78 | -1.8% | $595.52 | $596.09 | $581.82 | 179,900 | |
| $593.99 | -6.66 | -1.1% | $594.32 | $597.62 | $583.16 | 347,300 | |
| $600.65 | -10.92 | -1.8% | $605.79 | $609.22 | $599.36 | 186,900 | |
| $611.57 | -7.48 | -1.2% | $617.55 | $624.99 | $606.19 | 198,200 | |
| $619.05 | +4.99 | +0.8% | $607.86 | $620.58 | $605.63 | 149,400 | |
| $614.06 | -5.97 | -1.0% | $620.01 | $625.44 | $607.99 | 247,100 | |
| $620.03 | -0.72 | -0.1% | $614.15 | $622.49 | $612.00 | 186,200 | |
| $620.75 | +8.11 | +1.3% | $614.13 | $629.69 | $600.01 | 225,900 | |
| $612.64 | +4.37 | +0.7% | $597.75 | $627.59 | $597.41 | 254,500 |
- Ticker
- NASDAQ:MEDP
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 21, 2026
Medpace Holdings, Inc. Reports Third Quarter 2026 Results
Latest earnings call · Oct 22, 2026
Medpace Holdings (NASDAQ:MEDP) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Oct 21, 2026
Q3 2026 Earnings Presentation
Earnings · 15 slides
Latest news
Medpace Holdings, Inc. Reports Third Quarter 2026 Results
Oct 21, 2026
Closed $653.96 (-1.3%) on Oct 22, 2026
Medpace Holdings, Inc. to Report Third Quarter 2026 Financial Results on October 21, 2026
Sep 22, 2026
Closed $617.15 (-2.1%) on Sep 23, 2026
Medpace Holdings, Inc. Reports Second Quarter 2026 Results
Jul 22, 2026
Closed $605.82 (+14.7%) on Jul 23, 2026
Medpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026
Jun 16, 2026
Closed $457.09 (-1.0%) on Jun 17, 2026
Medpace Holdings, Inc. Reports First Quarter 2026 Results
Apr 22, 2026
Closed $393.42 (-22.6%) on Apr 23, 2026
Medpace Holdings, Inc. to Report First Quarter 2026 Financial Results on April 22, 2026
Mar 24, 2026
Closed $460.74 (+0.8%) on Mar 24, 2026
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Results
Feb 9, 2026
Closed $446.05 (-15.9%) on Feb 10, 2026
Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 9, 2026
Jan 5, 2026
Closed $586.83 (+2.8%) on Jan 5, 2026
Medpace Holdings, Inc. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 8 in the last 12 months · 66 in all · newest Oct 21, 2026 · oldest 2019
- Calls
- 24 calls with a replay · 24 with a transcript · latest Oct 22, 2026
- Decks
- 50 decks · latest Oct 21, 2026
Where Medpace Holdings, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:MEDP · Home listing · This page | NASDAQ | United States | USD |
| gettex:01P | gettex | Germany | EUR |
| Frankfurt:01P | Frankfurt | Germany | EUR |
| LS Exchange:A2APTV | LS Exchange | Germany | EUR |
| Tradegate:01P | Tradegate | Germany | EUR |
| BMV:MEDP | BMV | Mexico | MXN |
| BOATS:MEDP | BOATS | United States | USD |
| Lang & Schwarz:A2APTV | Lang & Schwarz | Germany | EUR |
| Milan:1MEDP | Milan | Italy | EUR |
| BIVA:MEDP | BIVA | Mexico | MXN |
| Dusseldorf:01P | Dusseldorf | Germany | EUR |
| Stuttgart:01P | Stuttgart | Germany | EUR |
| BX Swiss:MEDP | BX Swiss | Switzerland | CHF |
| Hamburg:01P | Hamburg | Germany | EUR |
| Munich:01P | Munich | Germany | EUR |
| Hanover:01P | Hanover | Germany | EUR |
| Xetra:01P | Xetra | Germany | EUR |
Valuation
P/E 33.0× against a median of 32.1×: 7th lowest of 10 Diagnostics & research services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $16.37B USD
- P/E
- 33.0×
- EV/sales
- 5.8×
- EV/EBITDA
- 25.8×
- Price/book
- 29.2×
- Gross margin
- Not reported
- Operating margin
- 21.4%
- Net margin
- 18.2%
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 0.72
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Medpace Holdings, Inc. · NASDAQ:MEDP | US$17.08B | US$16.37B | 33.0× | 5.8× | 25.8× | 29.2× | 18.2% | 0.0× | 0.72 |
| Illumina, Inc. · NASDAQ:ILMN | US$29.15B | US$27.82B | 32.6× | n/a | n/a | 9.3× | n/a | 0.0× | 1.14 |
| Wuxi Biologics (Cayman) Inc. · HKEX:2269 | US$21.51B | US$19.96B | 29.3× | 6.1× | 15.9× | 3.0× | 22.5% | 0.1× | n/a |
| Guardant Health, Inc. · NASDAQ:GH | US$19.73B | US$20.20B | n/a | 15.8× | n/a | n/a | −37.9% | n/a | 1.16 |
| Revvity, Inc. · NYSE:RVTY | US$16.21B | US$18.25B | 64.0× | 6.2× | 23.3× | 2.2× | 8.6% | 0.4× | 1.12 |
| Charles River Laboratories International, Inc. · NYSE:CRL | US$15.06B | US$14.86B | 375× | 3.7× | 33.5× | 4.7× | 1.0% | 0.0× | 1.23 |
| ICON plc · NASDAQ:ICLR | US$14.41B | US$16.98B | 32.1× | 2.1× | 15.7× | 1.6× | 5.5% | 0.4× | 1.08 |
| bioMerieux SA · EURONEXT:BIM | US$11.79B | US$11.53B | 27.0× | 2.6× | 10.9× | 2.5× | 9.8% | 0.1× | n/a |
| Bio-Techne Corp · NASDAQ:TECH | US$11.41B | US$11.35B | 66.4× | 9.2× | 33.6× | 5.3× | 14.0% | 0.1× | 0.54 |
| Qiagen N.V. · NYSE:QGEN | US$10.18B | US$11.03B | 24.9× | 5.3× | 15.0× | 3.0× | 19.5% | 0.5× | 0.33 |
| Avantor, Inc. · NYSE:AVTR | US$10.06B | US$13.28B | 29.8× | 2.0× | 14.7× | 1.7× | 5.1% | 0.6× | 0.78 |
| Median of the others | US$14.73B | US$15.92B | 32.1× | 5.3× | 15.8× | 3.0× | 8.6% | 0.1× | 1.10 |
Forecasts
1 strong buy · 1 buy · 11 hold · 1 strong sell · Analysts' consensus from EODHD, read Nov 19, 2026. Not 6ix's view and not investment advice.
- Price target
- 651.31 USD · Analysts' mean
- EPS, year to Dec 2026
- 18.36 · 11 analysts
- Revenue, year to Dec 2026
- 2.85B · 13 analysts
Team and board
| Officer | Role |
|---|---|
| August Troendle | President, Chief Executive Officer, and Chairman of the Board of Directors |
| Kevin Brady | Chief Financial Officer |
| Stephen Ewald | General Counsel, Chief Compliance Officer and Corporate Secretary |
| Brad Hansman | Executive Vice President, Operations |
| Gina Leisring | Senior Vice President, Clinical Monitoring & Phase I Unit |
| Jennifer Gehlhar | Vice President, Quality Assurance |
| Susan Burwig | Executive Vice President, Operations |
| Todd Meyers | Vice President, Business Development and Marketing |
| Traci Turner | Vice President, MRL Operations and MARC |
| Weimin Gai | Senior Vice President, Biometrics |
| Chris Carissimi | Chief Information Officer |
| John T. Wynne | Chief Business Officer |
| Reinilde Heyrman | Chief Medical Officer, Medical Department |
Events
Calls
| Call | When | Status |
|---|---|---|
| Medpace Holdings (NASDAQ:MEDP) Q3 2026 Earnings Call | Thu, Oct 22, 2026 · 9:00 AM ET | Replay |
| Medpace Holdings (NASDAQ:MEDP) Q2 2026 Earnings Call | Thu, Jul 23, 2026 · 9:00 AM ET | Replay |
| Medpace Holdings (NASDAQ:MEDP) Q1 2026 Earnings Call | Thu, Apr 23, 2026 · 9:00 AM ET | Replay |
| Medpace Holdings (NASDAQ:MEDP) Q4 2025 Earnings Call | Tue, Feb 10, 2026 · 9:00 AM ET | Replay |
| Medpace Holdings (NASDAQ:MEDP) Q3 2025 Earnings Call | Thu, Oct 23, 2025 · 9:00 AM ET | Replay |
| Medpace Holdings (NASDAQ:MEDP) Q2 2025 Earnings Call | Tue, Jul 22, 2025 · 9:00 AM ET | Replay |
| Medpace Holdings (NASDAQ:MEDP) Q1 2025 Earnings Call | Tue, Apr 22, 2025 · 9:00 AM ET | Replay |
| Medpace Holdings (NASDAQ:MEDP) Q4 2024 Earnings Call | Tue, Feb 11, 2025 · 9:00 AM ET | Replay |
| Medpace Holdings (NASDAQ:MEDP) Q3 2024 Earnings Call | Tue, Oct 22, 2024 · 9:00 AM ET | Replay |
| Medpace Holdings (NASDAQ:MEDP) Q2 2024 Earnings Call | Tue, Jul 23, 2024 · 9:00 AM ET | Replay |
All 24 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Oct 21, 2026 · After close | −1.3% |
| Q2 2026 | Jul 22, 2026 · After close | +14.7% |
| Q1 2026 | Apr 22, 2026 · After close | −22.6% |
| Q4 2025 | Feb 9, 2026 | −17.7% |
| Q3 2025 | Oct 22, 2025 · After close | +9.1% |
| Q2 2025 | Jul 21, 2025 · After close | +54.7% |
| Q1 2025 | Apr 21, 2025 · After close | −2.3% |
| Q4 2024 | Feb 10, 2025 · Before open | +0.1% |
| Q3 2024 | Oct 21, 2024 · After close | −7.5% |
| Q2 2024 | Jul 22, 2024 · After close | −18.3% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | Apr 22, 2024 · After close | +8.2% |
| Q4 2023 | Feb 12, 2024 · After close | +12.3% |
| Q3 2023 | Oct 23, 2023 · After close | +19.7% |
| Q2 2023 | Jul 24, 2023 · After close | +3.9% |
| Q1 2023 | Apr 24, 2023 · After close | +11.2% |
| Q4 2022 | Feb 13, 2023 · After close | −5.1% |
| Q3 2022 | Oct 24, 2022 · After close | +37.7% |
| Q2 2022 | Jul 25, 2022 · After close | −6.2% |
| Q1 2022 | Apr 25, 2022 · After close | −10.4% |
| Q4 2021 | Feb 14, 2022 · After close | −20.3% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2026 Earnings Presentation | Earnings | 15 slides | Oct 21, 2026 |
| Q2 2026 Earnings Presentation | Earnings | 15 slides | Jul 23, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 15 slides | Apr 23, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 15 slides | Feb 10, 2026 |
| Q3 2025 Earnings Presentation | Earnings | 15 slides | Oct 22, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 15 slides | Jul 22, 2025 |
| Investor Presentation (May 2025) | Investor deck | 17 slides | May 2025 |
| Q1 2025 Earnings Presentation | Earnings | 15 slides | Apr 22, 2025 |
| Q4 2024 Earnings Presentation | Earnings | 15 slides | Feb 11, 2025 |
| Q3 2024 Earnings Presentation | Earnings | 15 slides | Oct 22, 2024 |
All 50 decks
IPO
Priced at US$23.00 a share on Aug 10, 2016.
- Price
- US$23.00 a share
- Shares offered
- 7,000,000 shares of common stock
- Offering size
- US$161 million
- Underwriters' option
- Up to 1,050,000 more shares
- Underwriters
- Jefferies, Credit Suisse, UBS Investment Bank, Wells Fargo Securities, Baird, William Blair · In the order on the cover
- Shares delivered
- On or about Aug 16, 2016
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Mar 15, 2016 |
| Filed publicly | Jun 24, 2016 |
| Amended twice | Newest Aug 1, 2016 |
| Shares registered with an exchange | Aug 9, 2016 |
| Declared effective by the SEC | Aug 10, 2016 |
| Final prospectus, with the price | Aug 11, 2016 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Aug 11, 2016 |
| EFFECT · Notice that a registration is effective | Aug 10, 2016 |
| CERTNAS · Nasdaq's certificate of listing | Aug 10, 2016 |
| 8-A12B · Registration of shares for listing on an exchange | Aug 9, 2016 |
| CORRESP · Letter to the SEC | Aug 8, 2016 |
| CORRESP · Letter to the SEC | Aug 8, 2016 |
| S-1/A · Registration statement, amended | Aug 1, 2016 |
| CORRESP · Letter to the SEC | Jul 28, 2016 |
| S-1/A · Registration statement, amended | Jul 26, 2016 |
| CORRESP · Letter to the SEC | Jul 15, 2016 |
All 24 filings
| Filing | Filed |
|---|---|
| UPLOAD · Letter from the SEC | Jul 11, 2016 |
| CORRESP · Letter to the SEC | Jul 1, 2016 |
| CORRESP · Letter to the SEC | Jun 24, 2016 |
| S-1 · Registration statement | Jun 24, 2016 |
| DRSLTR · Letter to the SEC with a draft | Jun 10, 2016 |
| UPLOAD · Letter from the SEC | Jun 2, 2016 |
| DRSLTR · Letter to the SEC with a draft | May 25, 2016 |
| DRS/A · Draft registration statement, amended | May 25, 2016 |
| UPLOAD · Letter from the SEC | May 6, 2016 |
| DRSLTR · Letter to the SEC with a draft | Apr 27, 2016 |
| DRS/A · Draft registration statement, amended | Apr 27, 2016 |
| UPLOAD · Letter from the SEC | Apr 12, 2016 |
| DRSLTR · Letter to the SEC with a draft | Mar 15, 2016 |
| DRS · Draft registration statement | Mar 15, 2016 |
Open IPO · From the cover of the final prospectus (424B4) filed Aug 11, 2016
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.53B | 2.11B | 1.89B | 1.46B | 1.14B | 925.9M | 861.0M | 704.6M | 436.2M | 421.6M |
| Selling, general and administrative | 197.6M | 180.2M | 161.4M | 131.4M | 108.4M | 92.2M | 95.2M | 75.7M | 63.4M | 61.5M |
| Operating income | 534.9M | 446.9M | 336.8M | 278.7M | 198.6M | 167.0M | 127.3M | 101.0M | 64.9M | 52.5M |
| Depreciation and amortization | 27.2M | 27.8M | 24.1M | 19.0M | 16.0M | 11.7M | 8.36M | 9.24M | 8.57M | 7.44M |
| EBITDA | 562.1M | 474.7M | 361.0M | 297.7M | 214.6M | 178.7M | 135.6M | 110.3M | 73.4M | 59.9M |
| Income before tax | 542.4M | 475.9M | 335.7M | 282.9M | 201.9M | 168.5M | 124.8M | 94.0M | 56.9M | 22.0M |
| Income tax | 91.3M | 71.5M | 52.9M | 37.5M | 20.0M | 23.1M | 24.4M | 20.8M | 17.8M | 8.53M |
| Net income | 451.1M | 404.4M | 282.8M | 245.4M | 181.8M | 145.4M | 100.4M | 73.2M | 39.1M | 13.4M |
| Earnings per share, basic | 15.64 | 13.06 | 9.20 | 7.57 | 5.06 | 4.07 | 2.79 | 2.05 | 1.00 | 0.38 |
| Earnings per share, diluted | 15.28 | 12.63 | 8.88 | 7.28 | 4.81 | 3.84 | 2.67 | 1.97 | 0.98 | 0.37 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 497.0M | 669.4M | 245.4M | 28.3M | 461.3M | 277.8M | 131.9M | 23.3M | 26.5M | 37.1M |
| Receivables | 402.1M | 296.4M | 298.4M | 253.4M | 186.4M | 161.0M | 155.7M | 133.4M | 83.1M | 79.8M |
| Current assets | 989.6M | 1.03B | 593.8M | 334.0M | 690.9M | 473.7M | 317.0M | 178.1M | 130.0M | 133.2M |
| Property, plant and equipment | 131.1M | 123.6M | 120.6M | 109.8M | 93.2M | 85.0M | 47.3M | 52.3M | 48.7M | 43.8M |
| Goodwill | 662.4M | 662.4M | 662.4M | 662.4M | 662.4M | 662.4M | 662.4M | 661.0M | 661.0M | 661.0M |
| Total assets | 1.98B | 2.10B | 1.66B | 1.35B | 1.66B | 1.39B | 1.14B | 967.9M | 950.7M | 979.1M |
| Accounts payable | 28.1M | 32.5M | 31.9M | 33.1M | 25.7M | 26.6M | 22.4M | 16.7M | 16.7M | 10.9M |
| Current liabilities | 1.34B | 1.10B | 925.1M | 803.5M | 557.2M | 440.1M | 343.0M | 257.0M | 192.7M | 168.6M |
| Long-term debt | 0 | 79.7M | 205.1M | 151.3M | ||||||
| Total debt | 0 | 79.7M | 221.6M | 165.0M | ||||||
| Total liabilities | 1.52B | 1.28B | 1.10B | 966.1M | 707.0M | 584.9M | 416.8M | 378.2M | 447.2M | 368.4M |
| Shareholders' equity | 459.1M | 825.5M | 559.0M | 386.4M | 952.9M | 805.8M | 726.3M | 598.9M | 509.3M | 610.7M |
| Shares outstanding | 28.4M | 30.6M | 30.8M | 31.1M | 36.0M | 35.5M | 36.1M | 35.7M | 35.5M | 40.7M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 713.2M | 608.8M | 433.4M | 388.1M | 263.3M | 258.7M | 201.9M | 156.6M | 97.4M | 91.7M |
| Capital spending | -31.4M | -36.5M | -36.6M | -36.9M | -28.3M | -31.3M | -17.9M | -16.0M | -11.7M | -13.5M |
| Free cash flow | 681.9M | 572.3M | 396.7M | 351.2M | 235.1M | 227.3M | 184.0M | 140.6M | 85.7M | 78.2M |
| Cash from investing | -31.1M | -28.3M | -34.6M | -38.7M | -31.4M | -31.2M | -19.1M | -17.0M | -12.2M | -13.4M |
| Cash from financing | -860.4M | -154.0M | -182.6M | -775.8M | -44.5M | -82.3M | -73.9M | -141.6M | -97.8M | -58.0M |
| Share buybacks | -917.4M | -169.9M | -144.0M | -847.8M | -62.1M | -98.3M | 0 | 0 | -155.6M | 0 |
| Change in cash | -172.4M | 424.0M | 217.2M | -433.0M | 183.5M | 145.8M | 108.6M | -3.21M | -10.9M | 19.7M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 16, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 13, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 2, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 29, 2026 | Other filings | SEC |
| 4 · Change in ownership | Oct 28, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 27, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 26, 2026 | Other filings | SEC |
| 4 · Change in ownership | Oct 23, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Oct 22, 2026 | Quarterly report | SEC |
| 8-K · Current report | Oct 21, 2026 | Results | SEC |
All 932 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Oct 14, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 29, 2026 | Insider trade | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Sep 28, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Sep 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 21, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 31, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 27, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 26, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 24, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 21, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 21, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 21, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 20, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 19, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 19, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 14, 2026 | Insider trade | SEC |
| SCHEDULE 13G · Big-stake notice | Aug 14, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Aug 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 12, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 11, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 11, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 7, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jul 29, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 29, 2026 | Insider trade | SEC |
| 144/A · Notice of proposed sale, amended | Jul 29, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jul 28, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jul 28, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jul 27, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jul 23, 2026 | Other filings | SEC |
| 10-Q · Quarterly report | Jul 23, 2026 | Quarterly report | SEC |
| 8-K · Current report | Jul 22, 2026 | Results | SEC |
| 4 · Change in ownership | Jul 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 2, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jun 4, 2026 | Insider trade | SEC |
| 8-K · Current report | Jun 4, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Jun 1, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 28, 2026 | Other filings | SEC |
| 8-K · Current report | May 19, 2026 | Meeting outcome | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 28, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Apr 23, 2026 | Quarterly report | SEC |
| 8-K · Current report | Apr 22, 2026 | Results | SEC |
| 4 · Change in ownership | Apr 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 2, 2026 | Insider trade | SEC |
| DEFA14A · Additional proxy material | Apr 1, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 1, 2026 | Meeting notice | SEC |
| ARS · Annual report to shareholders | Apr 1, 2026 | Annual report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 27, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 19, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 17, 2026 | Other filings | SEC |
| PRE 14A · Preliminary proxy statement | Mar 16, 2026 | Meeting notice | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 17, 2026 | Insider trade | SEC |
| 10-K · Annual report | Feb 10, 2026 | Annual report | SEC |
| 8-K · Current report | Feb 9, 2026 | Results | SEC |
| 4 · Change in ownership | Jan 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Dec 9, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 2, 2025 | Insider trade | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Dec 1, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Dec 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 26, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 25, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 25, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 24, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 24, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 21, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 14, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 14, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 12, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 12, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 12, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 7, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 5, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 3, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 30, 2025 | Other filings | SEC |
| 4 · Change in ownership | Oct 29, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 29, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 29, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 29, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 27, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 27, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 27, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Oct 23, 2025 | Quarterly report | SEC |
| 8-K · Current report | Oct 22, 2025 | Results | SEC |
| 4 · Change in ownership | Oct 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 30, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 5, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 3, 2025 | Other filings | SEC |
| 4 · Change in ownership | Sep 3, 2025 | Insider trade | SEC |
| 144/A · Notice of proposed sale, amended | Aug 28, 2025 | Other filings | SEC |
| 4 · Change in ownership | Aug 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 28, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 27, 2025 | Other filings | SEC |
| 4 · Change in ownership | Aug 21, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 19, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jul 29, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 29, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 29, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 28, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jul 28, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Jul 28, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Jul 28, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jul 24, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jul 24, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Jul 24, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jul 22, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Jul 22, 2025 | Quarterly report | SEC |
| 8-K · Current report | Jul 21, 2025 | Results | SEC |
| 4 · Change in ownership | Jul 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2025 | Insider trade | SEC |
| 8-K · Current report | May 16, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Apr 28, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Apr 24, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Apr 22, 2025 | Quarterly report | SEC |
| 8-K · Current report | Apr 21, 2025 | Results | SEC |
| 4 · Change in ownership | Apr 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 2, 2025 | Insider trade | SEC |
| DEFA14A · Additional proxy material | Apr 2, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 2, 2025 | Meeting notice | SEC |
| ARS · Annual report to shareholders | Apr 2, 2025 | Annual report | SEC |
| 8-K · Current report | Mar 31, 2025 | Material contract | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Mar 11, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 26, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Feb 24, 2025 | Other filings | SEC |
| 10-K · Annual report | Feb 11, 2025 | Annual report | SEC |
| 8-K · Current report | Feb 10, 2025 | Results | SEC |
| 4 · Change in ownership | Jan 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 10, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 3, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 3, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 3, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Nov 21, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | Oct 22, 2024 | Quarterly report | SEC |
| 8-K · Current report | Oct 21, 2024 | Results | SEC |
| 4 · Change in ownership | Oct 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 26, 2024 | Insider trade | SEC |
Cap table
Built by 6ix from Medpace Holdings, Inc.’s releases · as of Oct 16, 2026
- Common shares
- 27,971,686
- Fully diluted
- 27,971,686
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 27,971,686 | Oct 16, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Oct 16, 2026 | 27,971,686 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Bruce Brown Other companies: Innventure, Inc. (Lead Independent Director · Since at least Oct 2, 2024); Magnera Corporation (Director · Since at least May 5, 2016) | Director · Oct 27, 2016 – May 17, 2019 · Past |
| Robert Kraft Other companies: Hillman Solutions Corp. (CFO and Treasurer · Since at least Sep 11, 2026) | Director · Since at least Mar 31, 2026 |
| Alexander F S Leslie | Director · Aug 10, 2016 – Aug 10, 2016 · Past |
| August Troendle | President, Chief Executive Officer, and Chairman of the Board of Directors · Since at least Apr 22, 2026 |
| Brad Hansman | Executive Vice President, Operations · Since at least Nov 4, 2026 |
| Brad W Hansman | Exec. VP, Operations · Since at least Jun 1, 2026 |
| Chris Carissimi | Chief Information Officer · Since at least Nov 4, 2026 |
| Cornelius P McCarthy III | Director · Since at least May 17, 2019 |
| Dani S Zander | Director · Since at least Jul 1, 2024 |
| Femida H Gwadry-Sridhar | Director · Since at least Jan 16, 2023 |
All 24 people
| Person | Seat |
|---|---|
| Fred B Davenport Jr | Director · Since at least Aug 19, 2026 |
| Gina Leisring | Senior Vice President, Clinical Monitoring & Phase I Unit · Since at least Nov 5, 2026 |
| Jennifer Gehlhar | Vice President, Quality Assurance · Since at least Nov 5, 2026 |
| Jesse J Geiger | President · Since at least Aug 10, 2016 |
| John T. Wynne | Chief Business Officer · Since at least Nov 5, 2026 |
| Kevin Brady | CFO & Treasurer · Since at least Aug 5, 2024 |
| Matthew Richard Norton | Director · Aug 10, 2016 – Aug 10, 2016 · Past |
| Reinilde Heyrman | Chief Medical Officer, Medical Department · Since at least Nov 5, 2026 |
| Stephen Ewald | General Counsel, Chief Compliance Officer and Corporate Secretary · Since at least Nov 2, 2026 |
| Susan Burwig | Executive Vice President, Operations · Since at least Oct 28, 2026 |
| Todd Meyers | Vice President, Business Development and Marketing · Since at least Nov 5, 2026 |
| Tom C King | Director · Oct 24, 2019 – May 20, 2022 · Past |
| Traci Turner | Vice President, MRL Operations and MARC · Since at least Nov 5, 2026 |
| Weimin Gai | Senior Vice President, Biometrics · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about Medpace Holdings, Inc.